Phathom

[anonymous]

Lmao yes fuck that guy

Jeeze dude fuck off… Sorry for thinking the celgene team with a novel drug would be a good investment. Didnt expect them to bring a band of losers on board

 

[anonymous]

Is anyone taking vacation?

 

[anonymous]

Of course. Why wouldn’t we? Especially since it’s ‘unlimited’.

 

[anonymous]

Is anyone taking vacation?

Sure. My manager takes a vacation every other week.

 

[anonymous]

Ok good to hear lol

 

[anonymous]

Is anyone taking vacation?

Yep like the entire summer.

 

[anonymous]

Yep like the entire summer.

Put in for it ASAP as senior management has said they will not approve vacations during summer launch timeframe.

 

[anonymous]

Put in for it ASAP as senior management has said they will not approve vacations during summer launch timeframe.

Honestly go for it, you idiots already screwed this launch up

 

[anonymous]

Any insight on working with Maral Suakjian?

 

[anonymous]

Honestly go for it, you idiots already screwed this launch up

Yep, keeping using the salesforce as scapegoats for the obvious inefficiencies of senior mgmnt/marketing/market access/etc….

 

[anonymous]

Who is Maral?

 

[A man called uncle]

WTH is commission capped? Forced ranking is stupid. This isn’t the ymca.
Also, approving PTO is laughable. Is there even a way to submit pto for approval? I just put it in veeva as a decree, not a request. Lol

 

[anonymous]

WTH is commission capped? Forced ranking is stupid. This isn’t the ymca.
Also, approving PTO is laughable. Is there even a way to submit pto for approval? I just put it in veeva as a decree, not a request. Lol

Yes it is capped. No bonus at all if you can’t get 50 TRX’s filled. Segment assigned based on you total PPI potential but goals are the same for lowest segment vs the highest segment. Your manager approves time off.

 

[anonymous]

Anyone foresee how NERD will go?

 

[anonymous]

Anyone foresee how NERD will go?

Not much interest. Good drug but providers.dont want the headaches of PAing.to.get.thw drug. Sad but true.

 

[anonymous]

Anyone foresee how NERD will go?

I think it's going to go really good. Drug will be a blockbuster in two years

 

[anonymous]

I think it's going to go really good. Drug will be a blockbuster in two years

Two years? They will need to make major changes.

 

[anonymous]

If you were a Director at Phathom and received $0 quarterly bonus bc managers did not hit bonus what would you do?

 

[anonymous]

By the time we come even close to a blockbuster, our patent will shortly expire

I think the bigger worry is other PCABs entering the US market before the patentlife expires (e.g., tegoprazan, which I think is finishing phase 3 Q4 of this year for EE and NERD...).

 

[anonymous]

I think the bigger worry is other PCABs entering the US market before the patentlife expires (e.g., tegoprazan, which I think is finishing phase 3 Q4 of this year for EE and NERD...).

• Patent expiration dates:
  • August 11, 2028
    ✓
    Drug substance
• Pharmaceutical composition
  Patent 9,186,411
  Issued: November 17, 2015
  Inventor(s): Hiraishi Yasuhiro & Nonomura Muneo
  Assignee(s): Takeda Pharmaceutical Company Limited
  The present invention provides a pharmaceutical composition or a solid preparation containing a stabilized pharmaceutically active ingredient and a stabilizing method thereof.
  Patent expiration dates:
  • August 11, 2030
    ✓
    Drug product

Related exclusivities​

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • November 1, 2026 - NEW PRODUCT
  • May 3, 2027 - NEW CHEMICAL ENTITY